MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-02-0028030
Avert Pharma Private Limited
Avert Pharma Private Limited - pharma in Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹54.61 Lakh
▲ 4% YoY
Net profit · FY 2024
₹55,737
Net margin 1%
EBITDA · FY 2024
₹75,615
EBITDA margin 1.4%
Authorised capital
₹2 Lakh
Registered with MCA
Paid-up capital
₹2 Lakh
Issued & subscribed
Company age
16 yrs
Est. 2010
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Avert Pharma Private Limited
Data last updated:
Avert Pharma Private Limited is a private limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 10 March 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U36101DL2010PTC199918. Its GSTIN is 09AAICA2800M1ZN (Uttar Pradesh).
The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors Satish Chand and Satendra Singh.
Its last annual general meeting (AGM) was held on 28 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A – 15 Phase – 10 Shiv Vihar Karawal Nagar Delhi 110094, Delhi, India – 110094.
As per the financials filed for FY 2024, the company reported a revenue of ₹54.61 Lakh, a growth of 4% compared to the previous year. For the same year it recorded a net profit of ₹55,737 (net margin 1%) and EBITDA of ₹75,615 (EBITDA margin 1.4%). Revenue has declined at a compounded annual rate (CAGR) of 8% over three years and 2% over five years.
Avert Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-02-0028030). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U36101DL2010PTC199918
Registration Number 199918
Incorporation Date 10 March 2010
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 28 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-DL-02-0028030
Key People
Satish Chand Director Satendra Singh Director Recognitions & Rankings of Avert Pharma
Contact details
Avert Pharma Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressA – 15 Phase – 10 Shiv Vihar Karawal Nagar Delhi 110094, Delhi, India – 110094
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Avert Pharma Private Limited, buy the company report.
Comprehensive company report
Avert Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Avert Pharma is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Avert Pharma Private Limited, buy the company report.
Financials of Avert Pharma Private Limited
FY 2025 filings availableAvert Pharma Private Limited reported revenue of ₹54.61 Lakh (up 4% YoY) for FY 2024.
Revenue · FY 2024
₹54.61 Lakh ▲ 4%
Net profit · FY 2024
₹55,737 margin 1%
EBITDA · FY 2024
₹75,615 margin 1.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 4%
3 years · compounded
▲ 8%
5 years · compounded
▼ 2%
EBITDA CAGR growth
1 year
▲ 5%
3 years · compounded
▲ 3%
5 years · compounded
▼ 13%
Revenue rose 4% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 2%. EBITDA rose 5% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹75,615 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹55,737 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.4% | ||||
| Net Profit Margin | 1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Avert Pharma Private Limited, buy the company report.
Board of directors of Avert Pharma Private Limited
Avert Pharma has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Satish Chand | Director | 10 Mar 2010 | 16 Years 7 Months | Current |
| Satendra Singh | Director | 10 Mar 2010 | 16 Years 7 Months | Current |
Peer comparison
Avert Pharma Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trade, except of motor vehicles and motorcycles), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Richmel Life Sciences Private Limited | ₹54.79 Lakh (FY 2024) | -66.0% | Delhi, India | |||
| Avert Pharma Private Limitedthis company | ₹54.61 Lakh (FY 2024) | ₹55,737 | 1% | 4.0% | Delhi, India | |
| Bajaj Lifesciences Private Limited | ₹54.52 Lakh (FY 2024) | -73.0% | Mumabi, Maharashtra, India | |||
| Macto Pharmaceuticals Private Limited | ₹54.33 Lakh (FY 2025) | -10.0% | Visakhapatnam, Andhra Pradesh, India |
To see the full peer comparison of Avert Pharma Private Limited, buy the company report.
Auditor
Avert Pharma Private Limited is audited by R.S.DANI &CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| R.S.DANI &CO | FY 2023 | 000243C |
Shareholding
The shareholding of Avert Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2021 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Avert Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Avert Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Avert Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Avert Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAICA2800M1ZN | Uttar Pradesh | Active | 22 Aug 2017 |
To see the full GST registrations and return filing status of Avert Pharma Private Limited, buy the company report.
Recent activity
Avert Pharma Private Limited has 2 board changes on record since 2010: 2 appointments. The latest: Satendra Singh was appointed as Director on 10 Mar 2010.
AGM
Avert Pharma Private Limited last Annual general meeting of members was held on 28 Sep 2025 as per latest MCA records.
Filing
Avert Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Appointed
Satendra Singh was appointed as Director.
Appointed
Satish Chand was appointed as Director.
Incorporation
10 Mar 2010
Avert Pharma Private Limited was registered on 10 Mar 2010 with Roc Delhi & aged 16 years 7 months as per MCA records.
Frequently asked questions
Avert Pharma is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 10 March 2010 (16+ years old) and is registered under CIN U36101DL2010PTC199918.
Avert Pharma has 2 current directors:
- Satish Chand - Director
- Satendra Singh - Director
The latest financial statements of Avert Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 28 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Avert Pharma is 09AAICA2800M1ZN, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Avert Pharma is U36101DL2010PTC199918. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Avert Pharma was incorporated on 10 March 2010, making it 16+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Avert Pharma by revenue are Richmel Life Sciences Private Limited, Bajaj Lifesciences Private Limited, Macto Pharmaceuticals Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trade, except of motor vehicles and motorcycles).
Satendra Singh was appointed as Director on 10 Mar 2010. Satish Chand was appointed as Director on 10 Mar 2010.
Yes, Avert Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-02-0028030).
The registered office of Avert Pharma is at A – 15 Phase – 10 Shiv Vihar Karawal Nagar Delhi 110094, Delhi, India – 110094.
Avert Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.